{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"13","upperLimit":"38","value":"19"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"24"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"38"}],"units":"MNC collections"}],"description":"Platelet contamination of the cell product was measured as the platelet collection efficiency, that is, as the percent of platelets processed that were collected.","dispersionType":"Full Range","groups":[{"description":"Multiple myeloma patients infused with autologous peripheral blood stem cells collected on the Spectra Optia Apheresis System.","id":"OG000","title":"All Per Protocol Patients"}],"paramType":"MEDIAN","populationDescription":"Data to calculate platelet collection efficiency was available for 38 MNC collections on 24 of the 26 per protocol patients.","reportingStatus":"POSTED","timeFrame":"up to 7 days","title":"Platelet Collection Efficiency","type":"SECONDARY","typeUnitsAnalyzed":"MNC collections","unitOfMeasure":"% of processed platelets collected"}